Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]
Gastroparesis Drugs Market size to increase by USD 1.42 Billion between 2023 to 2028, Market Segmentation by Drug Class, Disease Type, Geography, Technavio [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $80.00 price target on the stock.
Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? [Yahoo! Finance]